Prolacta Bioscience
City Of Industry
About Prolacta Bioscience
Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill, premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $78.0M
- Last round: Series Unknown (May 2018)
- Website: prolacta.com
- Phone: 6265999269
Industries & Categories
Biotechnology, Health Care, Life Science, Nutrition
Social Profiles
Canonical: https://fsome.com/organization/prolacta-bioscience-46642 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.